High Cardiovascular Risk and Frequent Cardiovascular Medication Use Among Oral Anticoagulant-Naive Initiators of Rivaroxaban and Vitamin K Antagonists

Nov-18

AUTHORS : Dr Luis A. Garcia Rodríguez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: lagarcia@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : Circulation

REFERENCE: 138(S1):A14106

DOI : 10.1161/circ.138.suppl_1.14106

High Cardiovascular Risk and Frequent Cardiovascular Medication Use Among Oral Anticoagulant-Naive Initiators of Rivaroxaban and Vitamin K Antagonists

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study